Palisade Bio (PALI) Operating Leases (2019 - 2024)
Palisade Bio's (PALI) quarterly Operating Leases came in at $24000.0 in Q2 2024, down 84.31% year-on-year from $153000.0 in Q3 2023, and down 58.62% on a QoQ basis from $58000.0 in Q1 2024.
Palisade Bio (PALI) Operating Leases (2019 - 2024) Analysis & Trends
Palisade Bio (PALI) has 6 years of Operating Leases data on file, last reported at $24000.0 in Q2 2024.
- On a quarterly basis, Operating Leases fell 84.31% year-over-year to $24000.0 in Q2 2024; TTM through Jun 2024 was $24000.0, a 84.31% decrease from a year earlier, with the FY2023 full-year figure at $90000.0, down 57.35% from the prior year.
- Operating Leases for Q2 2024 stood at $24000.0, down from $58000.0 in the prior quarter.
- Over the last five years, Operating Leases for PALI reached as high as $364000.0 in Q2 2022 and fell as low as $24000.0 in Q2 2024.
- Historically, Operating Leases has averaged $155754.6 across 5 years, with a median of $144697.5 in 2020.
- Across the five-year window, Operating Leases jumped 81.09% in 2022 and sank 84.31% in 2024, its largest moves.
- Year by year, Operating Leases stood at $112000.0 in 2020, then soared by 79.46% to $201000.0 in 2021, then rose by 4.98% to $211000.0 in 2022, then plunged by 57.35% to $90000.0 in 2023, then plunged by 73.33% to $24000.0 in 2024.
- Per Business Quant data, the three most recent Operating Leases figures were $24000.0 in Q2 2024, $58000.0 in Q1 2024, and $90000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Jun 30, 2022 | 364,000.00 |
| Jun 30, 2021 | 201,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 159,400.00 |
| Jun 30, 2020 | 128,770.00 |
| Mar 31, 2020 | 136,395.00 |
| Dec 31, 2019 | 148,543.00 |
| Sep 30, 2019 | 152,632.00 |